Sort by
Refine Your Search
-
of the person appointed will be to evaluate the mode of action of novel metal based antifungal agents and to assist in the development of these for pulmonary delivery. Post Doctoral Researcher (2025) Salary Scale
-
of novel metal based antifungal agents and to assist in the development of these for pulmonary delivery. Post Doctoral Researcher (2025) Salary Scale: €45,847 - €48,411
-
. The researcher will lead the ongoing development of a techno-economic Web-GIS tool for offshore renewable energy, secure competitive research funding, engage in the wider research activities of the ORE Group and
-
of Computer Science and Information Technology, to work on Insight Platform research in the area of multi-agent pathfinding in dynamic environments. In addition, the researcher may contribute to various other
-
silico work, including sequence design, data analysis, experimental planning, and writing publications. The postdoc will work closely with the PI and a PhD student. An ideal candidate must hold, or be
-
writing publications. The postdoc will work closely with the PI and a PhD student. An ideal candidate must hold, or be on the verge of holding, a PhD in a relevant field, such as DNA nanotechnology
-
Science, Computer Engineering, Informatics, Data Science, Computational Social Science, or adjacent disciplines with research experience in agent-based modelling, social data science, or social network analysis and
-
closely with the Principle Investigator on all aspects of the project goals listed above. The Postdoc will assist in developing surveys (student/staff/industry), analysing the data, writing reports and
-
, for example, a cautious agent such as an autonomous device may wish to avoid false negatives and so considers every piece evidence, even if contradictory. A human operated device however may want to avoid a
-
the chemical synthesis of a range of candidate compounds, oversee their formulation into drug delivery vehicles with the ultimate goal of achieving demonstration of potential for new therapeutic agents against